Raju Prasad
Vermogen: 874 442 $ op 31-05-2026
Vermogen: 874 442 $ op 31-05-2026
Raju Prasad is currently Chief Financial & Accounting Officer at CRISPR Therapeutics AG since 2023.
Formerly, Dr. Prasad was a Research Analyst at William Blair & Co. LLC from 2014 to 2023 and a Research Associate at the University of North Carolina at Chapel Hill.
Education includes an undergraduate degree from Rutgers State University of New Jersey, a graduate degree from the University of Delaware, and a doctorate from The University of North Carolina at Charlotte.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 29-05-2026 | 15.565 ( 0,02% ) | 874 442 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CRISPR THERAPEUTICS AG | Financieel Directeur/CFO | 14-03-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
William Blair & Co. LLC
William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01-03-2023 |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
William Blair & Co. LLC
William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau